The Ming You lab focuses upon the identification of candidate lung cancer susceptibility genes by capture-sequencing of targeted regions or genes, identification of frequent somatic mutations in lung adenocarcinomas and squamous cell carcinomas by exome sequencing, and identification of those somatic mutations predictive of clinical outcome of stage I NSCLC by SNP genotyping.
Ming You, MD, PhD
Research Scientist, Research Institute
Director, Center for Cancer Prevention, Dr. Mary and Ron Neal Cancer Center
Dr. You is a member of the Board of Scientific Counselors of the National Cancer Institute. He is a current member and past chair of the Chemo/Dietary Prevention Study Section (CDP) and a member of the Chemical Pathology Study Section (CPA) at the National Institutes of Health. Dr. You also served as a member of the NCI’s Cancer Susceptibility Think Tank and Cancer Chemoprevention Think Tank and the chair of the Review Panel for Chemopreventive Agent Development Research Group (CADRG), Division of Cancer Prevention at the National Cancer Institute. He is an Associate Editor of Cancer Research and Cancer Prevention Research and is on the editorial board of PLoS One and Carcinogenesis